AIDS Healthcare Foundation (AHF) supports and applauds the Colombian government’s decision to utilize a compulsory license to import cheaper generic versions of ViiV Healthcare’s HIV treatment dolutegravir. The country spends …
Newly Approved Malaria Vaccine Is a Win for Global Health
AIDS Healthcare Foundation (AHF) applauds the World Health Organization’s (WHO) recommendation of a new malaria vaccine, R21/Matrix-M, for preventing malaria, which disproportionately affects African children. The affordable and easily deployable vaccine is a …
J&J Patent Move Must be First of Many
AIDS Healthcare Foundation (AHF) acknowledged today pharmaceutical company Johnson & Johnson’s (J&J) announcement that it will not enforce its patent for the multi-drug resistant tuberculosis treatment SIRTURO (bedaquiline) for 134 …
Disappointment and Hope after U.N. General Assembly Wraps
The weeklong 78th U.N. General Assembly concluded today in New York City with the adoption of declarations on pandemic prevention, preparedness, and response (PPPR), tuberculosis (TB), and universal health coverage …
Findings Spotlight Urgent Need for Europe to Step-up on AIDS
In response to the European Centre for Disease Prevention and Control (ECDC) reporting dangerous gaps in HIV/AIDS diagnosis and treatment coverage in many countries across the region, the AIDS Healthcare …
AHF Slams Johnson & Johnson for Immoral Profiteering on TB Treatment
The AIDS Healthcare Foundation (AHF) today strongly condemned pharma giant Johnson & Johnson (J&J) for again putting profits before people’s lives by charging South Africa more than twice what many other countries …
AHF Hails African Union Taking a Seat at the G20 Table
AIDS Healthcare Foundation (AHF) praised today the ascension of the Africa Union (AU) to permanent membership in the G20, which was made official during the G20 summit in India this …
AHF Slams J&J’s Vaccine Hostage Tactics in South Africa
According to a Health Policy Watch story, Johnson & Johnson (J&J) used scarcity during the COVID-19 pandemic as leverage to charge South Africa inflated prices on vaccine doses – a tactic …
J&J-Stop TB Partnership Deal a Positive Step but More Is Needed
With Johnson and Johnson (J&J) recently granting permission to Stop TB Partnership to distribute its generic TB drug bedaquiline (SIRTURO) to the majority of low- and middle-income countries, AIDS Healthcare …
Investigation of COVID-19 Origins Must Continue
With the origins of COVID-19 still undetermined after a recently released report did not prove it started from either a lab leak or an animal host, AIDS Healthcare Foundation (AHF) …
